HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Borhane Annabi Selected Research

AD4 015

5/2010Inhibition of tubulogenesis and of carcinogen-mediated signaling in brain endothelial cells highlight the antiangiogenic properties of a mumbaistatin analog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Borhane Annabi Research Topics

Disease

60Neoplasms (Cancer)
04/2022 - 01/2002
23Glioblastoma (Glioblastoma Multiforme)
11/2021 - 01/2002
23Brain Neoplasms (Brain Tumor)
02/2016 - 11/2003
11Inflammation (Inflammations)
01/2018 - 03/2002
10Glioma (Gliomas)
01/2017 - 01/2003
9Neoplasm Metastasis (Metastasis)
11/2021 - 01/2005
6Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2019
5Medulloblastoma
02/2013 - 11/2003
4Neuroinflammatory Diseases
01/2014 - 01/2011
4Hypoxia (Hypoxemia)
01/2011 - 01/2003
3Fibrosarcoma
01/2017 - 01/2005
3Necrosis
04/2007 - 06/2006
2Breast Neoplasms (Breast Cancer)
10/2021 - 01/2015
2Triple Negative Breast Neoplasms
10/2021 - 10/2020
2Carcinoma (Carcinomatosis)
01/2021 - 01/2021
2Carcinogenesis
01/2019 - 11/2003
2Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2014
2Hemangioma (Angioma)
11/2010 - 11/2009
2Atherosclerosis
12/2007 - 07/2002
2Prostatic Neoplasms (Prostate Cancer)
07/2006 - 05/2006
1Endometrial Neoplasms (Endometrial Cancer)
04/2022
1Obesity
03/2022
1Experimental Melanoma
12/2021
1Melanoma (Melanoma, Malignant)
12/2021
1Lymphoma (Lymphomas)
12/2021
1Neutropenia
10/2021
1Lymphatic Metastasis
10/2021
1Weight Loss (Weight Reduction)
10/2020
1Circulating Neoplastic Cells
10/2020

Drug/Important Bio-Agent (IBA)

30Matrix Metalloproteinases (MMPs)IBA
11/2021 - 01/2002
23Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2021 - 01/2002
16Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2011
14Proteins (Proteins, Gene)FDA Link
04/2018 - 01/2003
11Concanavalin AIBA
11/2021 - 01/2002
8Peptides (Polypeptides)IBA
04/2022 - 01/2005
8PolyphenolsIBA
03/2022 - 01/2002
8TeaIBA
03/2022 - 01/2002
8Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2016 - 03/2009
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2014 - 01/2003
6progelatinaseIBA
01/2018 - 01/2002
6Glucose-6-PhosphateIBA
05/2010 - 03/2006
5epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2022 - 11/2003
5Transforming Growth Factors (Transforming Growth Factor)IBA
11/2021 - 01/2017
5matrigelIBA
01/2021 - 04/2004
4Pharmaceutical PreparationsIBA
04/2022 - 07/2004
4Oxygen (Dioxygen)IBA
01/2021 - 01/2003
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017 - 03/2010
4LectinsIBA
05/2014 - 03/2010
4sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2014 - 03/2006
4Biological ProductsIBA
03/2010 - 07/2002
4tigapotideIBA
07/2006 - 01/2005
3sortilinIBA
04/2022 - 01/2021
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2012
3FlavonoidsIBA
01/2015 - 01/2011
3CaveolinsIBA
12/2014 - 05/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2009 - 05/2006
3Amino AcidsFDA Link
05/2006 - 01/2005
2Docetaxel (Taxotere)FDA Link
04/2022 - 10/2021
2Transcription Factors (Transcription Factor)IBA
10/2021 - 01/2011
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 06/2012
2Anthocyanins (Anthocyanin)IBA
04/2018 - 01/2017
2Matrix Metalloproteinase InhibitorsIBA
12/2017 - 05/2004
2Recombinant ProteinsIBA
02/2016 - 03/2007
2Complementary DNA (cDNA)IBA
02/2016 - 09/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 04/2014
2Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
01/2016 - 01/2006
2CytokinesIBA
04/2014 - 01/2003
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014 - 06/2008
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2013 - 05/2013
2CarcinogensIBA
01/2012 - 06/2008
2Propranolol (Inderal)FDA LinkGeneric
11/2010 - 11/2009
2NF-kappa B (NF-kB)IBA
03/2010 - 03/2009
2CalciumIBA
03/2008 - 03/2006
2PlasminogenIBA
12/2007 - 09/2005
2Cytochalasin DIBA
04/2007 - 01/2002
2Small Interfering RNA (siRNA)IBA
03/2007 - 06/2006
2Chlorogenic AcidIBA
12/2006 - 03/2006
2Antineoplastic Agents (Antineoplastics)IBA
12/2006 - 06/2006
2Hormones (Hormone)IBA
07/2006 - 05/2006
2Messenger RNA (mRNA)IBA
03/2006 - 01/2003
2Hyaluronic Acid (Hyaluronan)IBA
08/2005 - 05/2004
2Conditioned Culture MediaIBA
04/2004 - 01/2003
1Taxoids (Taxanes)IBA
04/2022
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1Carboplatin (JM8)FDA LinkGeneric
04/2022
1EpitopesIBA
12/2021
1AntibodiesIBA
12/2021
1VaccinesIBA
12/2021
1RNA (Ribonucleic Acid)IBA
11/2021
1Fibronectins (Fibronectin)IBA
11/2021
1human ERBB2 proteinIBA
10/2021
1LigandsIBA
10/2021
1Estrogen ReceptorsIBA
10/2021
1Phosphotransferases (Kinase)IBA
01/2021
1gingerolIBA
10/2020
1PeriostinIBA
04/2018
1Endoplasmic Reticulum Chaperone BiPIBA
01/2018

Therapy/Procedure

20Therapeutics
10/2021 - 04/2004
3Drug Therapy (Chemotherapy)
10/2020 - 08/2011
3Radiotherapy
11/2006 - 11/2003